BioGaia AB (publ) (LON:0GTN)
99.77
+0.05 (0.05%)
At close: Jul 28, 2025
BioGaia AB Revenue
BioGaia AB had revenue of 404.69M SEK in the quarter ending June 30, 2025, with 5.36% growth. This brings the company's revenue in the last twelve months to 1.44B, up 5.14% year-over-year. In the year 2024, BioGaia AB had annual revenue of 1.42B with 9.73% growth.
Revenue (ttm)
1.44B SEK
Revenue Growth
+5.14%
P/S Ratio
7.08
Revenue / Employee
6.40M SEK
Employees
225
Market Cap
782.40M GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.42B | 126.21M | 9.73% |
Dec 31, 2023 | 1.30B | 192.55M | 17.44% |
Dec 31, 2022 | 1.10B | 318.85M | 40.61% |
Dec 31, 2021 | 785.11M | 38.03M | 5.09% |
Dec 31, 2020 | 747.08M | -21.27M | -2.77% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
HSBC Holdings | 44.89B |
Shell | 217.54B |
Unilever | 50.25B |
British American Tobacco p.l.c. | 25.87B |
Rolls-Royce Holdings | 18.91B |
Rio Tinto Group | 42.86B |
RELX PLC | 9.53B |